Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
2.930
-0.030 (-1.01%)
Apr 1, 2025, 3:53 PM EDT - Market open
Puma Biotechnology Employees
Puma Biotechnology had 172 employees as of December 31, 2024. The number of employees decreased by 13 or -7.03% compared to the previous year.
Employees
172
Change (1Y)
-13
Growth (1Y)
-7.03%
Revenue / Employee
$1,339,930
Profits / Employee
$176,035
Market Cap
145.36M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
PBYI News
- 1 day ago - Puma SE: Undervalued With Tailwinds Ahead - Seeking Alpha
- 6 days ago - Puma Biotechnology to Present Clinical Data on Neratinib at the AACR Annual Meeting 2025 - Business Wire
- 11 days ago - PUMA SE: This Is The Right Time To Buy - Seeking Alpha
- 26 days ago - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 26 days ago - Puma Biotechnology to Present at Barclays Annual Global Healthcare Conference - Business Wire
- 4 weeks ago - Puma Biotechnology, Inc. (PBYI) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Puma Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results - Business Wire
- 4 weeks ago - Puma Biotechnology to Present at TD Cowen's 45th Annual Health Care Conference - Business Wire